|
1
|
Tian Y, Deng P, Li B, Wang J, Li J, Huang
Y and Zheng Y: Treatment models of cardiac rehabilitation in
patients with coronary heart disease and related factors affecting
patient compliance. Rev Cardiovasc Med. 20:27–33. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khamis RY, Ammari T and Mikhail GW: Gender
differences in coronary heart disease. Heart. 102:1142–1149. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orme RC, Parker WAE, Thomas MR, Judge HM,
Baster K, Sumaya W, Morgan KP, McMellon HC, Richardson JD, Grech
ED, et al: Study of two dose regimens of ticagrelor compared with
clopidogrel in patients undergoing percutaneous coronary
intervention for stable coronary artery disease (STEEL-PCI).
Circulation. Jun 21–2018.(Epub ahead of print) doi:
10.1161/CIRCULATIONAHA.118.034790. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee MS, Cheng RK, Kandzari DE and Kirtane
AJ: Long-term outcomes of heart transplantation recipients with
transplant coronary artery disease who develop in-stent restenosis
after percutaneous coronary intervention. Am J Cardiol.
109:1729–1732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prasad K: Do statins have a role in
reduction/prevention of post-PCI restenosis? Cardiovasc Ther.
31:12–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang CY, Fang HY, Chen CJ, Yang CH, Wu CJ
and Lee WC: Comparison of clinical outcomes after drug-eluting
balloon and drug-eluting stent use for in-stent restenosis related
acute myocardial infarction: A retrospective study. PeerJ.
6:e46462018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee KJ, Park SH, Lee JY, Joo HC, Jang EH,
Youn YN and Ryu W: Perivascular biodegradable microneedle cuff for
reduction of neointima formation after vascular injury. J Control
Release. 192:174–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ishimura S, Furuhashi M, Mita T, Fuseya T,
Watanabe Y, Hoshina K, Kokubu N, Inoue K, Yoshida H and Miura T:
Reduction of endoplasmic reticulum stress inhibits neointima
formation after vascular injury. Sci Rep. 4:69432014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guan H, Gao L, Zhu L, Yan L, Fu M, Chen C,
Dong X, Wang L, Huang K and Jiang H: Apigenin attenuates neointima
formation via suppression of vascular smooth muscle cell phenotypic
transformation. J Cell Biochem. 113:1198–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Chen J, Xu C, Yang J, Guo Q, Hu Q
and Jiang H: Resveratrol inhibits phenotypic switching of
neointimal vascular smooth muscle cells after balloon injury
through blockade of Notch pathway. J Cardiovasc Pharmacol.
63:233–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang L, Dai F, Liu Y, Yu X, Huang C, Wang
Y and Yao W: RhoA/ROCK signaling regulates smooth muscle phenotypic
modulation and vascular remodeling via the JNK pathway and vimentin
cytoskeleton. Pharmacol Res. 133:201–212. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang F, Chen Q, He S, Yang M, Maguire EM,
An W, Afzal TA, Luong LA, Zhang L and Xiao Q: miR-22 is a novel
mediator of vascular smooth muscle cell phenotypic modulation and
neointima formation. Circulation. 137:1824–1841. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hasanov Z, Ruckdeschel T, König C, Mogler
C, Kapel SS, Korn C, Spegg C, Eichwald V, Wieland M, Appak S and
Augustin HG: Endosialin promotes atherosclerosis through phenotypic
remodeling of vascular smooth muscle cells. Arterioscler Thromb
Vasc Biol. 37:495–505. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi N, Li CX, Cui XB, Tomarev SI and Chen
SY: Olfactomedin 2 regulates smooth muscle phenotypic modulation
and vascular remodeling through mediating runt-related
transcription factor 2 binding to serum response factor.
Arterioscler Thromb Vasc Biol. 37:446–454. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang JC, Li GY, Wang B, Han SX, Sun X,
Jiang YN, Shen YW, Zhou C, Feng J, Lu SY, et al: Metformin inhibits
metastatic breast cancer progression and improves chemosensitivity
by inducing vessel normalization via PDGF-B downregulation. J Exp
Clin Cancer Res. 38:2352019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hellström M, Kalén M, Lindahl P, Abramsson
A and Betsholtz C: Role of PDGF-B and PDGFR-beta in recruitment of
vascular smooth muscle cells and pericytes during embryonic blood
vessel formation in the mouse. Development. 126:3047–3055.
1999.PubMed/NCBI
|
|
17
|
Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao
T, Miyazaki H and Iwao H: Role of JNK, p38, and ERK in
platelet-derived growth factor-induced vascular proliferation,
migration, and gene expression. Arterioscler Thromb Vasc Biol.
23:795–801. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Satoh K, Kikuchi N, Kurosawa R and
Shimokawa H: PDE1C negatively regulates growth factor receptor
degradation and promotes VSMC proliferation. Circ Res.
116:1098–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou T, Tong C, Kazobinka G, Zhang W, Huang
X, Huang Y and Zhang Y: Expression of COL6A1 predicts prognosis in
cervical cancer patients. Am J Transl Res. 8:2838–2844.
2016.PubMed/NCBI
|
|
20
|
Wan F, Wang H, Shen Y, Zhang H, Shi G, Zhu
Y, Dai B and Ye D: Upregulation of COL6A1 is predictive of poor
prognosis in clear cell renal cell carcinoma patients. Oncotarget.
6:27378–27387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nandakumar P, Lee D, Richard MA,
Tekola-Ayele F, Tayo BO, Ware E, Sung YJ, Salako B, Ogunniyi A, Gu
CC, et al: Rare coding variants associated with blood pressure
variation in 15 914 individuals of African ancestry. J Hypertens.
35:1381–1389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sleptsov AA, Nazarenko MS, Lebedev IN,
Skriabin NA, Frolov AV, Popov VA, Barbarash LS and Puzyrev VP:
Somatic genome variations in vascular tissues and peripheral blood
leukocytes in patients with atherosclerosis. Genetika. 50:986–995.
2014.(In Russian). PubMed/NCBI
|
|
23
|
Chiu KH, Chang YH, Wu YS, Lee SH and Liao
PC: Quantitative secretome analysis reveals that COL6A1 is a
metastasis-associated protein using stacking gel-aided purification
combined with iTRAQ labeling. J Proteome Res. 10:1110–1125. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang MJ, Zhou Y, Chen L, Wang YQ, Wang X,
Pi Y, Gao CY, Li JC and Zhang LL: An overview of potential
molecular mechanisms involved in VSMC phenotypic modulation.
Histochem Cell Biol. 145:119–130. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fellows BD, Ghobrial N, Mappus E, Hargett
A, Bolding M, Dean D and Mefford OT: In vitro studies of
heparin-coated magnetic nanoparticles for use in the treatment of
neointimal hyperplasia. Nanomedicine. 14:1191–1200. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen S, Liu B, Kong D, Li S, Li C, Wang H
and Sun Y: Atorvastatin calcium inhibits phenotypic modulation of
PDGF-BB-induced VSMCs via down-regulation the Akt signaling
pathway. PLoS One. 10:e01225772015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sato T, Takano R, Tokunaka K, Saiga K,
Tomura A, Sugihara H, Hayashi T, Imamura Y and Morita M: Type VI
collagen α1 chain polypeptide in non-triple helical form is an
alternative gene product of COL6A1. J Biochem. 164:173–181. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Prado AF, Pernomian L, Azevedo A, Costa
RAP, Rizzi E, Ramos J, Paes Leme AF, Bendhack LM, Tanus-Santos JE
and Gerlach RF: Matrix metalloproteinase-2-induced epidermal growth
factor receptor transactivation impairs redox balance in vascular
smooth muscle cells and facilitates vascular contraction. Redox
Biol. 18:181–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ou YC, Li JR, Wang JD, Chang CY, Wu CC,
Chen WY, Kuan YH, Liao SL, Lu HC and Chen CJ: Fibronectin promotes
cell growth and migration in human renal cell carcinoma cells. Int
J Mol Sci. 20:E27922019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dhar S, Sun Z, Meininger GA and Hill MA:
Nonenzymatic glycation interferes with fibronectin-integrin
interactions in vascular smooth muscle cells. Microcirculation.
24:2017.doi: 10.1111/micc.12347. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hunter MC, O'Hagan KL, Kenyon A, Dhanani
KC, Prinsloo E and Edkins AL: Hsp90 binds directly to fibronectin
(FN) and inhibition reduces the extracellular fibronectin matrix in
breast cancer cells. PLoS One. 9:e868422014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang M, Fan Z, Wang F, Tian ZH, Ma B, Dong
B, Li Z, Zhang M and Zhao W: BMP-2 enhances the migration and
proliferation of hypoxia-induced VSMCs via actin cytoskeleton, CD44
and matrix metalloproteinase linkage. Exp Cell Res. 368:248–257.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yin J, Xia W, Wu M, Zhang Y, Huang S,
Zhang A and Jia Z: Inhibition of mitochondrial complex I activity
attenuates neointimal hyperplasia by inhibiting smooth muscle cell
proliferation and migration. Chem Biol Interact. 304:73–82. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song IS, Jeong YJ, Park JH, Shim S and
Jang SW: Chebulinic acid inhibits smooth muscle cell migration by
suppressing PDGF-Rβ phosphorylation and inhibiting matrix
metalloproteinase-2 expression. Sci Rep. 7:117972017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Seo KW, Lee SJ, Ye BH, Kim YW, Bae SS and
Kim CD: Mechanical stretch enhances the expression and activity of
osteopontin and MMP-2 via the Akt1/AP-1 pathways in VSMC. J Mol
Cell Cardiol. 85:13–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Smiljanic K, Obradovic M, Jovanovic A,
Djordjevic J, Dobutovic B, Jevremovic D, Marche P and Isenovic ER:
Thrombin stimulates VSMC proliferation through an EGFR-dependent
pathway: Involvement of MMP-2. Mol Cell Biochem. 396:147–160. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu Q, Lin X, Ding L, Zeng Y, Pang D,
Ouyang N, Xiang Y and Yao H: ARHGAP42 promotes cell migration and
invasion involving PI3K/Akt signaling pathway in nasopharyngeal
carcinoma. Cancer Med. 7:3862–3874. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Han R, Gu S, Zhang Y, Luo A, Jing X, Zhao
L, Zhao X and Zhang L: Estrogen promotes progression of
hormone-dependent breast cancer through CCL2-CCR2 axis by
upregulation of Twist via PI3K/AKT/NF-kappaB signaling. Sci Rep.
8:95752018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou H, Wu Q, Wei L and Peng S:
Paeoniflorin inhibits PDGFBBinduced human airway smooth muscle cell
growth and migration. Mol Med Rep. 17:2660–2664. 2018.PubMed/NCBI
|
|
41
|
Chan CM, Chang HH, Wang VC, Huang CL and
Hung CF: Inhibitory effects of resveratrol on PDGF-BB-induced
retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and
MAPK pathways. PLoS One. 8:e568192013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang H, Yin Y, Li W, Zhao X, Yu Y, Zhu J,
Qin Z, Wang Q, Wang K, Lu W, et al: Over-expression of PDGFR-β
promotes PDGF-induced proliferation, migration, and angiogenesis of
EPCs through PI3K/Akt signaling pathway. PLoS One. 7:e305032012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cidad P, Miguel-Velado E, Ruiz-McDavitt C,
Alonso E, Jiménez-Pérez L, Asuaje A, Carmona Y, García-Arribas D,
López J, Marroquín Y, et al: Kv1.3 channels modulate human vascular
smooth muscle cells proliferation independently of mTOR signaling
pathway. Pflugers Arch. 467:1711–1722. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lu QB, Wan MY, Wang PY, Zhang CX, Xu DY,
Liao X and Sun HJ: Chicoric acid prevents PDGF-BB-induced VSMC
dedifferentiation, proliferation and migration by suppressing
ROS/NFκB/mTOR/P70S6K signaling cascade. Redox Biol. 14:656–668.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pan S, Lin H, Luo H, Gao F, Meng L, Zhou
C, Jiang C, Guo Y, Ji Z, Chi J and Guo H: Folic acid inhibits
dedifferentiation of PDGF-BB-induced vascular smooth muscle cells
by suppressing mTOR/P70S6K signaling. Am J Transl Res. 9:1307–1316.
2017.PubMed/NCBI
|
